Rick Wise
Stock Analyst at Stifel
(4.36)
# 247
Out of 4,814 analysts
234
Total ratings
61.05%
Success rate
10.48%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $129.70 | +11.80% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $24.58 | +13.91% | 1 | Mar 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $32 | $20.59 | +55.42% | 6 | Mar 5, 2025 | |
| LIVN LivaNova | Maintains: Buy | $72 → $60 | $35.07 | +71.09% | 6 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $33 → $30 | $22.93 | +30.83% | 6 | Feb 25, 2025 | |
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $32.08 | +49.63% | 13 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $115 → $120 | $95.25 | +25.98% | 17 | Feb 10, 2025 | |
| CNMD CONMED | Maintains: Buy | $72 → $75 | $48.03 | +56.15% | 10 | Feb 6, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $75 → $90 | $71.20 | +26.40% | 23 | Jan 30, 2025 | |
| SYK Stryker | Maintains: Buy | $400 → $440 | $346.67 | +26.92% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $138 | $96.94 | +42.36% | 14 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $153.91 | +0.71% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $481.34 | +26.73% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $151.68 | +25.26% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $27.82 | +36.59% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $6.52 | +22.70% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $4.79 | +234.03% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $65.67 | +24.87% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $61.48 | +65.91% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $82.70 | +5.20% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $280 | $200.40 | +39.72% | 7 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $4.72 | +154.24% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $84.67 | -11.42% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $17.26 | +39.05% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $10.91 | +724.93% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $12.06 | +107.30% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $37.53 | +198.43% | 5 | Oct 2, 2020 |
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $129.70
Upside: +11.80%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $24.58
Upside: +13.91%
OrthoPediatrics
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $20.59
Upside: +55.42%
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $35.07
Upside: +71.09%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $22.93
Upside: +30.83%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $32.08
Upside: +49.63%
Boston Scientific
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $95.25
Upside: +25.98%
CONMED
Feb 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $48.03
Upside: +56.15%
Edwards Lifesciences
Jan 30, 2025
Upgrades: Buy
Price Target: $75 → $90
Current: $71.20
Upside: +26.40%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $346.67
Upside: +26.92%
Jan 23, 2025
Maintains: Buy
Price Target: $130 → $138
Current: $96.94
Upside: +42.36%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $153.91
Upside: +0.71%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $481.34
Upside: +26.73%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $151.68
Upside: +25.26%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $27.82
Upside: +36.59%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $6.52
Upside: +22.70%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $4.79
Upside: +234.03%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $65.67
Upside: +24.87%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $61.48
Upside: +65.91%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $82.70
Upside: +5.20%
Jul 26, 2024
Maintains: Buy
Price Target: $270 → $280
Current: $200.40
Upside: +39.72%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $4.72
Upside: +154.24%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $84.67
Upside: -11.42%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $17.26
Upside: +39.05%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $10.91
Upside: +724.93%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $12.06
Upside: +107.30%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $37.53
Upside: +198.43%